Pds Planning, Inc Scynexis Inc Call Options Transaction History
Pds Planning, Inc
- $1.42 Billion
- Q3 2025
Call Options
0 transactions
| Quarter | Operation | Price Per call | calls change | calls Held | SEC Form |
|---|
Others Institutions Holding SCYX
# of Institutions
48Shares Held
10.6MCall Options Held
0Put Options Held
0-
Kingdon Capital Management, L.L.C. New York, NY2.24MShares$1.48 Million0.23% of portfolio
-
Vanguard Group Inc Valley Forge, PA1.66MShares$1.09 Million0.0% of portfolio
-
Federated Hermes, Inc. Pittsburgh, PA1.58MShares$1.05 Million0.0% of portfolio
-
Avidity Partners Management LP Dallas, TX1.23MShares$811,0800.22% of portfolio
-
Decheng Capital Management Iii (Cayman), LLC556KShares$366,6660.7% of portfolio
About SCYNEXIS INC
- Ticker SCYX
- Exchange NASDAQ
- Sector Healthcare
- Industry Drug Manufacturers—Specialty & Generic
- Shares Outstandng 32,651,800
- Market Cap $21.6M
- Description
- SCYNEXIS, Inc., a biotechnology company, develops products for the treatment fungal infections in the United States. It offers BREXAFEMME (ibrexafungerp tablets) for the treatment of vulvovaginal candidiasis (VVC). The company is developing its lead product candidate, Ibrexafungerp, as a novel oral and intravenous drug for the treatment of vario...